title: Eager for better migraine therapies: keep your (telcage)PANTs on.
authors.affiliation: From the Department of Neurology (R.B.L.), Montefiore Headache Center, Albert Einstein College of Medicine, Bronx, NY; and the Neurology ANNR RehaClinic and University of Zurich (P.S.S.), Cantonal Hospital Baden, Switzerland. richard.lipton@einstein.yu.edu.
authors.forename: Richard B
authors.initials: RB
authors.lastname: Lipton
authors.affiliation: From the Department of Neurology (R.B.L.), Montefiore Headache Center, Albert Einstein College of Medicine, Bronx, NY; and the Neurology ANNR RehaClinic and University of Zurich (P.S.S.), Cantonal Hospital Baden, Switzerland.
authors.forename: Peter S
authors.initials: PS
authors.lastname: Sandor
mesh_terms: D001381:Azepines / Q000627:therapeutic use*; D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008881:Migraine Disorders / Q000517:prevention & control*
chemical_list: D001381:Azepines; D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D007093:Imidazoles; C525458:telcagepant